Scholars Central

Conference abstractPublished 11 Sep 2017

Synthesis and antiprotozoal activity of furanchalcone-quinoline, furanchalcone-chromone and furanchalcone-imidazole hybrids

Authors: Elisa Garcia, Juan C Coa, Miguel Carda, Ivan D Velez, Sara M Robledo, Wilson I Cardona

University of Antioquia, Colombia Jaume I University, Spain

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Statement of the Problem: Neglected tropical diseases (NTD) include, among others, ChagasÃ?Â?Ã?¢Ã?Â?Ã?Â?Ã?Â?Ã?Â? disease (American trypanosomiasis) caused by parasitic protozoan Trypanosoma cruzi and leishmaniasis caused by Leishmania species. These diseases affect more than 10 million people worldwide. Current chemotherapies for those diseases are based on old drugs, such as pentavalent antimonials (Meglumine antimoniate and Sodium stibogluconate) to treat cutaneous leishmaniasis and nitroaromatic compounds (Benznidazole and Nifurtimox) for treatment of Chagas disease. Unfortunately, all these drugs are not very effective in the chronic phase and have toxicity, side effects and parasite resistance. Strategies for the discovery and development of new drugs are necessaries for the use in the treatment of parasitic diseases. In recent years, a promising strategy has emerged based on hybrid molecules which bear in their structures two distinct pharmacophores. This type of molecules could improve the bioavailability and absorption and could enhance the antiprotozoal activity due a synergic mechanism. In this work, we are going to show the synthesis and biological activities (cytotoxicity, leishmanicidal and trypanocidal) of several furanchalcone-quinoline, furanchalcone-chromone and furanchalcone-imidazole hybrids. The final compounds showed yields between 16-46% for furanchalcone-quinoline hybrids, 7-33% for furanchalcone-chromone and 39-98% for furanchalconeimidazole. The synthetized compounds were evaluated against intracellular amastigotes of L. panamensis, and intracellular amastigotes of Trypanosoma cruzi. Cytotoxicity was evaluated against human U-937 macrophages. Briefly, although these compounds showed high toxicity for mammalian U-937 cells, most of the compounds were very active against T. cruzi and L. panamensis. Four compounds showed a high activity against L. panamensis and five compounds exhibited high activity against T. cruzi, all of them with effective concentration 50 (EC50) less than 10 Ã?Â?Ã?Â?Ã?Â?Ã?¼M. Furanchalcone-imidazole hybrids were the most active of all compounds, showing that the imidazole salt moiety is important for their biological actions.

Subjects

Chemistry

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Chemical Sciences Journal.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalChemical Sciences Journal
  • SubjectChemistry
  • BylineArticles whose byline prints “Elisa Garcia”
  • BylineArticles whose byline prints “Juan C Coa”
  • BylineArticles whose byline prints “Miguel Carda”
  • BylineArticles whose byline prints “Ivan D Velez”
  • BylineArticles whose byline prints “Sara M Robledo”
  • BylineArticles whose byline prints “Wilson I Cardona”